Jordi Camps

Kang, @JrdCamps, Fan, Jiang, Shen, Bu, @ZeminZhangLab, Roider & co use bulk and single-cell RNA-seq to profile the microenvironment of gastric cancer. An immunosuppressive microenvironment correlates with poor prognosis and resistance to anti-PD1 treatment genomebiology.biomedcentral.com/articles/10.11…

A great start of the new year as our multi-omics study in gastric cancer has been published in genome biology. #oncology #cancerresearch #Bayer #Fig2" target="_blank" rel="nofollow noopener">genomebiology.biomedcentral.com/articles/10.11…

My previous #job is back online. Represent #BayerAG in the IMMUcan consortium. Analyse and integrate multi-omics #data from large cancer patient cohorts treated with immune #oncology drugs. jobs.bayer.com/job/Berlin-IMI…

Join our data science team in Berlin as a clinical bioinformatics scientist. #Bayer jobs.bayer.com/job/Berlin-Cli…

At the #AACR22 annual meeting, #IMMUcan will be presenting a virtual poster. 🪧5011 - Meta-analysis of human #cancer single cell #RNAseq datasets using the fully integrated IMMUcan database Check it out: abstractsonline.com/pp8/#!/10517/p…

From our first publication, new partnerships, one in person meeting, & many poster presentations...it has been quite a year! As 2021 comes to a close, the #IMMUcan consortium wishes you a merry Christmas & a very happy & safe start to #NewYear2022. 💫See you on the other side!

A little xmas present🎅🏼: our benchmarking study on atlas-level data integration for both scRNA-seq & scATAC-seq out @naturemethods! Born in a group hackathon, great effort headed by @MDLuecken and with @colomemaria_epi. Detailed guide on method choice at nature.com/articles/s4159…

For the final research highlight of the year ⚡️ bioinformatician & #IMMUcan project partner, Daniel Herrero Saboya, chose this @CellPressNews study on the role of multimodal analyses to better understand the #ImmunoOncology picture Full statement below 🖇️bit.ly/3276FSX

For her research highlight⚡️Sylvie Rusakiewicz of @CHUVLausanne chose 2⃣ studies identifying how #patient specific #tumor characteristics correlate to survival in #melanoma- highlighting the importance of #IMMUcan's mission. 🖇️go.nature.com/3yeDmKa 🖇️bit.ly/3EHPxS7

Are you a genomicist who struggles with H&E slides (like me)? Check out our work to spatially define tumors by their genetic and transcriptomic alterations! Another amazing collaboration with @insitubiology, led by Tongtong Zhao and @z_chiang : nature.com/articles/s4158…

Pan cancer single cell landscape of tumor-infiltrating T cells. Very helpful resource for pharma! science.org/doi/10.1126/sc…

@IMMUCan @Nature @eupatientsforum @EORTC @IHIEurope Very proud to be working on this great consortium!

For @jrdcamps research highlight ⚡️he has chosen 2⃣ studies published in @Nature that combined experimental & computational approaches to understand which #Tcells can eliminate #tumor cells #cancer #immunology Studies linked: 🖇️go.nature.com/3pJbz0w 🖇️go.nature.com/3DIQPuC

@NilsEling Absolutely!

Really excited to support #IMMUcan with image and single-cell data analysis!

For her #CancerResearch highlight⚡️ of the year, Elisa Fontana chose 2 studies focusing on the role of high throughput technologies to understand response to #immunotherapy. Here, she shares how this is relevant for #IMMUcan: 📑go.nature.com/3lZTGcT 📑bit.ly/31BwpGS

Great opportunity in our bioinformatics team in Berlin @Bayer. We are looking for a senior lead data scientist in immuno-oncology. karriere.bayer.de/de/job/senior-…

For #LungCancerAwarenessMonth, we hear from one of #IMMUcan's principal investigators for #LungCancer: 'Besides being immediately useful for patients & their physician, the integration of this information will soon produce new knowledge for the benefit of all' His statement👇

I am happy to share the preprint of our workflow for #multiplexedimaging data processing and analysis developed by @JonasWindhager and @NilsEling. biorxiv.org/content/10.110…

Wondering how many cells, reads and samples you need for your next #scRNA-seq experiment? Check out scPower by @heinig_matthias lab, just out @NatureComms. General finding: more cells, less reads! scpower.helmholtz-muenchen.de nature.com/articles/s4146…

#LungCancerAwarenessMonth update 💡 This year, we began an exciting partnership with the @EORTC 1335 SPECTAlung #clinicalstudy, which will enable #IMMUcan to access relevant samples from 200+ #LungCancer patients 🫁 Learn more: immucan.eu